Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-01-04
1986-10-07
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31385
Patent
active
046160329
ABSTRACT:
A method of inhibiting monoamine oxidase-A in a mammal such as man, comprising administration to said mammal of an effective amount of a compound of formula (I') or a physiologically acceptable salt, or a pro-drug or metabolite thereof.
In formula (I') ##STR1## n is 0, 1 or 2; one of R.sup.1 and R.sup.2 is hydrogen and the other is a tetrazol-5-yl group optionally substituted by one or more C.sub.1-4 alkyl groups; and
REFERENCES:
patent: 3905989 (1975-09-01), Hodson et al.
patent: 4091108 (1978-05-01), Batchelor et al.
Sheehan, J. Clin. Psychiatry, 45:7 (1984), pp. 29-36.
Brown Donald
Burroughs Wellcome Co.
Friedman Stanley J.
LandOfFree
Use of nitrogen heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nitrogen heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nitrogen heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-643611